Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1998 Sep;79(3):242–245. doi: 10.1136/adc.79.3.242

Thyroid dysfunction in Down's syndrome: relation to age and thyroid autoimmunity

B Karlsson 1, J Gustafsson 1, G Hedov 1, S Ivarsson 1, G Anneren 1
PMCID: PMC1717691  PMID: 9875020

Abstract

BACKGROUND—The prevalence of thyroid disease is increased in Down's syndrome. Most available data come from cross sectional studies.
AIMS—To study longitudinally thyroid function in patients with Down's syndrome in Uppsala county (85 patients) up to the age of 25years.
METHODS—Observational study based on yearly follow up in a children's clinic. Thyroid function tests were performed at each visit to the clinic.
RESULTS—Hypothyroidism was found in 30 and hyperthyroidism was found in two of the 85 patients. No sex difference was seen. Half of the patients with hypothyroidism acquired the condition before the age of 8 years, but only one of them displayed thyroid autoantibodies at diagnosis. Most patients who developed hypothyroidism after this age had thyroid autoantibodies. In the prepubertal patients with hypothyroidism, growth velocity was lower during the year before the start of thyroxine treatment than during the year after treatment began; it was also lower than that of sex and age matched euthyroidic children with Down's syndrome.
CONCLUSION—Thyroid dysfunction in patients with Down's syndrome is common in childhood. Consequently, annual screening is important. Autoimmune thyroid disease is uncommon in young children with Down's syndrome but is common after 8 years of age.



Full Text

The Full Text of this article is available as a PDF (103.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Annerén G., Gustafsson J., Sara V. R., Tuvemo T. Normalized growth velocity in children with Down's syndrome during growth hormone therapy. J Intellect Disabil Res. 1993 Aug;37(Pt 4):381–387. doi: 10.1111/j.1365-2788.1993.tb00881.x. [DOI] [PubMed] [Google Scholar]
  2. Annerén G., Gustavson K. H., Sara V. R., Tuvemo T. Growth retardation in Down syndrome in relation to insulin-like growth factors and growth hormone. Am J Med Genet Suppl. 1990;7:59–62. doi: 10.1002/ajmg.1320370710. [DOI] [PubMed] [Google Scholar]
  3. Baxter R. G., Larkins R. G., Martin F. I., Heyma P., Myles K., Ryan L. Down syndrome and thyroid function in adults. Lancet. 1975 Oct 25;2(7939):794–796. doi: 10.1016/s0140-6736(75)80007-9. [DOI] [PubMed] [Google Scholar]
  4. Cronk C., Crocker A. C., Pueschel S. M., Shea A. M., Zackai E., Pickens G., Reed R. B. Growth charts for children with Down syndrome: 1 month to 18 years of age. Pediatrics. 1988 Jan;81(1):102–110. [PubMed] [Google Scholar]
  5. Cutler A. T., Benezra-Obeiter R., Brink S. J. Thyroid function in young children with Down syndrome. Am J Dis Child. 1986 May;140(5):479–483. doi: 10.1001/archpedi.1986.02140190089034. [DOI] [PubMed] [Google Scholar]
  6. Ericsson U. B., Larsson I., Murne A., Thorell J. I. A new sensitive immunosorbent radioassay for the detection of circulating antibodies to polypeptide hormones and proteins. Scand J Clin Lab Invest. 1984 Oct;44(6):487–493. doi: 10.3109/00365518409083601. [DOI] [PubMed] [Google Scholar]
  7. Fialkow P. J., Blumberg B. S., London W. T., Sutnick A. I., Thuline H. C. Thyroid antibodies and Australia antigen in Down's syndrome. J Ment Defic Res. 1971 Sep;15(3):177–180. doi: 10.1111/j.1365-2788.1971.tb01155.x. [DOI] [PubMed] [Google Scholar]
  8. Fort P., Lifshitz F., Bellisario R., Davis J., Lanes R., Pugliese M., Richman R., Post E. M., David R. Abnormalities of thyroid function in infants with Down syndrome. J Pediatr. 1984 Apr;104(4):545–549. doi: 10.1016/s0022-3476(84)80544-2. [DOI] [PubMed] [Google Scholar]
  9. Karlberg J., Fryer J. G., Engström I., Karlberg P. Analysis of linear growth using a mathematical model. II. From 3 to 21 years of age. Acta Paediatr Scand Suppl. 1987;337:12–29. doi: 10.1111/j.1651-2227.1987.tb17122.x. [DOI] [PubMed] [Google Scholar]
  10. Kinnell H. G., Gibbs N., Teale J. D., Smith J. Thyroid dysfunction in institutionalised Down's syndrome adults. Psychol Med. 1987 May;17(2):387–392. doi: 10.1017/s0033291700024946. [DOI] [PubMed] [Google Scholar]
  11. Korsager S., Chatham E. M., Ostergaard Kristensen H. P. Thyroid function tests in adults with Down's syndrome. Acta Endocrinol (Copenh) 1978 May;88(1):48–54. doi: 10.1530/acta.0.0880048. [DOI] [PubMed] [Google Scholar]
  12. Loudon M. M., Day R. E., Duke E. M. Thyroid dysfunction in Down's syndrome. Arch Dis Child. 1985 Dec;60(12):1149–1151. doi: 10.1136/adc.60.12.1149. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Murdoch J. C., Ratcliffe W. A., McLarty D. G., Rodger J. C., Ratcliffe J. G. Thyroid function in adults with Down's syndrome. J Clin Endocrinol Metab. 1977 Mar;44(3):453–458. doi: 10.1210/jcem-44-3-453. [DOI] [PubMed] [Google Scholar]
  14. Pueschel S. M., Annerén G., Durlach R., Flores J., Sustrová M., Verma I. C. Guidelines for optimal medical care of persons with Down syndrome. International League of Societies for Persons with Mental Handicap (ILSMH). Acta Paediatr. 1995 Jul;84(7):823–827. doi: 10.1111/j.1651-2227.1995.tb13768.x. [DOI] [PubMed] [Google Scholar]
  15. Pueschel S. M., Pezzullo J. C. Thyroid dysfunction in Down syndrome. Am J Dis Child. 1985 Jun;139(6):636–639. doi: 10.1001/archpedi.1985.02140080106045. [DOI] [PubMed] [Google Scholar]
  16. Radetti G., Drei F., Betterle C., Mengarda G. Down's syndrome, hypothyroidism and insulin-dependent diabetes mellitus. Helv Paediatr Acta. 1986 Oct;41(4):377–380. [PubMed] [Google Scholar]
  17. Rallison M. L., Dobyns B. M., Keating F. R., Rall J. E., Tyler F. H. Occurrence and natural history of chronic lymphocytic thyroiditis in childhood. J Pediatr. 1975 May;86(5):675–682. doi: 10.1016/s0022-3476(75)80350-7. [DOI] [PubMed] [Google Scholar]
  18. Rubello D., Pozzan G. B., Casara D., Girelli M. E., Boccato S., Rigon F., Baccichetti C., Piccolo M., Betterle C., Busnardo B. Natural course of subclinical hypothyroidism in Down's syndrome: prospective study results and therapeutic considerations. J Endocrinol Invest. 1995 Jan;18(1):35–40. doi: 10.1007/BF03349694. [DOI] [PubMed] [Google Scholar]
  19. Sare Z., Ruvalcaba R. H., Kelley V. C. Prevalence of thyroid disorder in Down syndrome. Clin Genet. 1978 Sep;14(3):154–158. doi: 10.1111/j.1399-0004.1978.tb02121.x. [DOI] [PubMed] [Google Scholar]
  20. Sharav T., Collins R. M., Jr, Baab P. J. Growth studies in infants and children with Down's syndrome and elevated levels of thyrotropin. Am J Dis Child. 1988 Dec;142(12):1302–1306. doi: 10.1001/archpedi.1988.02150120056040. [DOI] [PubMed] [Google Scholar]
  21. Thase M. E. Reversible dementia in Down's syndrome. J Ment Defic Res. 1982 Jun;26(Pt 2):111–113. doi: 10.1111/j.1365-2788.1982.tb00135.x. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES